Upgrade to SI Premium - Free Trial

Unicycive Therapeutics (UNCY) PT Lowered to $40 at Guggenheim

April 2, 2026 6:40 AM
(Updated - April 2, 2026 6:43 AM EDT)

Guggenheim analyst Vamil Divan lowered the price target on Unicycive Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change